Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Clemmensen

Showing results (91-100 of 95) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 95 results.
Acta Oncologica (Stockholm, Sweden)|January 1, 1996
Use of tetranectin, CA-125 and CASA to predict residual tumor and survival at second- and third-look operations for ovarian cancerC K Høgdall, E V Høgdall, U Hørding, et al.
Gynecologic Oncology|January 1, 1995
The role of serum tetranectin, CA 125, and a combined index as tumor markers in women with pelvic tumorsC K Høgdall, O Mogensen, A Tabor, et al.
International Journal of Cancer|June 8, 2000
Angiogenic balance in human melanoma: expression of VEGF, bFGF, IL-8, PDGF and angiostatin in relation to vascular density of xenografts in vivoJ R Westphal, R Van't Hullenaar, R Peek, et al.
The Journal of Pathology|July 1, 1996
Tetranectin and plasmin/plasminogen are similarly distributed at the invasive front of cutaneous melanoma lesionsT J De Vries, P E De Wit, I Clemmensen, et al.
International Journal of Cancer|June 8, 2000
Angiostatin generation by human tumor cell lines: involvement of plasminogen activatorsJ R Westphal, R Van't Hullenaar, A Geurts-Moespot, et al.
Pageof 10

Showing results (91-100 of 95) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 95 results.
Acta Oncologica (Stockholm, Sweden)|January 1, 1996
Use of tetranectin, CA-125 and CASA to predict residual tumor and survival at second- and third-look operations for ovarian cancerC K Høgdall, E V Høgdall, U Hørding, et al.
Gynecologic Oncology|January 1, 1995
The role of serum tetranectin, CA 125, and a combined index as tumor markers in women with pelvic tumorsC K Høgdall, O Mogensen, A Tabor, et al.
International Journal of Cancer|June 8, 2000
Angiogenic balance in human melanoma: expression of VEGF, bFGF, IL-8, PDGF and angiostatin in relation to vascular density of xenografts in vivoJ R Westphal, R Van't Hullenaar, R Peek, et al.
The Journal of Pathology|July 1, 1996
Tetranectin and plasmin/plasminogen are similarly distributed at the invasive front of cutaneous melanoma lesionsT J De Vries, P E De Wit, I Clemmensen, et al.
International Journal of Cancer|June 8, 2000
Angiostatin generation by human tumor cell lines: involvement of plasminogen activatorsJ R Westphal, R Van't Hullenaar, A Geurts-Moespot, et al.
Pageof 10